Literature DB >> 21088246

Prevalence of coronary atherosclerosis in patients with cerebral infarction.

Pierre Amarenco1, Philippa C Lavallée, Julien Labreuche, Gregory Ducrocq, Jean-Michel Juliard, Laurent Feldman, Lucie Cabrejo, Elena Meseguer, Celine Guidoux, Valérie Adraï, Samina Ratani, Jérôme Kusmierek, Bertrand Lapergue, Isabelle F Klein, Fernando Gongora-Rivera, Arturo Jaramillo, Mikael Mazighi, Pierre-Jean Touboul, Philippe Gabriel Steg.   

Abstract

BACKGROUND AND
PURPOSE: there is an overlap between stroke and coronary heart disease, but the exact prevalence of coronary artery disease in patients with nonfatal cerebral infarction is unclear, particularly when there is no known history of coronary heart disease.
METHODS: we consecutively enrolled 405 patients presenting with acute cerebral infarction documented by neuroimaging who underwent carotid and femoral artery, thoracic, and abdominal aorta ultrasound examinations. Of the 342 patients with no known coronary heart disease, 315 underwent coronary angiography a median of 8 days (interquartile range, 6-11) after stroke onset.
RESULTS: coronary plaques on angiography, regardless of stenosis severity, were present in 61.9% of patients (95% confidence interval [CI], 56.5-67.3) and coronary stenoses ≥ 50% were found in 25.7% (95% CI, 20.9-30.5). The overall prevalence of coronary plaque increased with the number of arterial territories (carotid or femoral arteries) involved, with an adjusted odds ratio of coronary artery disease of 1.25 (95% CI, 0.58-2.71) for presence of plaque in 1 territory, and 4.31 (95% CI, 1.92-9.68) for presence of plaque in both territories, compared with no plaque in either territory. The presence of plaque in both femoral and carotid arteries had an age- and sex-adjusted positive predictive value of 84% for presence of coronary plaque and a negative predictive value of 44%.
CONCLUSIONS: there is a high burden of silent coronary artery disease in patients with nonfatal cerebral infarction and no known coronary heart disease, even in the absence of systemic atherosclerosis. The prevalence is even higher in patients with evidence of carotid and/or femoral plaque.

Entities:  

Mesh:

Year:  2010        PMID: 21088246     DOI: 10.1161/STROKEAHA.110.584086

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  51 in total

1.  Likelihood of myocardial infarction during stroke rehabilitation preceded by cardiovascular screening and an exercise tolerance test: the Locomotor Experience Applied Post-Stroke (LEAPS) trial.

Authors:  Stephen E Nadeau; Dorian Kay Rose; Bruce Dobkin; Samuel S Wu; Yufeng E Dai; Richard Schofield; Pamela W Duncan
Journal:  Int J Stroke       Date:  2014-08-26       Impact factor: 5.266

2.  Non-neurological complications of acute stroke: frequency and influence on clinical outcome.

Authors:  Andrea Alberti; Giancarlo Agnelli; Valeria Caso; Michele Venti; Monica Acciarresi; Cataldo D'Amore; Maurizio Paciaroni
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

3.  Incremental prognostic value of computed tomography in stroke: rationale and design of the IMPACTS study.

Authors:  Ji Won Lee; Jin Hur; Sang Il Choi; Eun Ju Chun; Joon-Won Kang; Gong Yong Jin; Eun Young Kim; Hwan Seok Yong; Eun-Ju Kang; Kyunghwa Han; Hoon-Suk Lee; Byoung Wook Choi
Journal:  Int J Cardiovasc Imaging       Date:  2016-02-24       Impact factor: 2.357

4.  The Impact of Myocardial Infarction vs. Pneumonia on Outcome in Acute Ischemic Stroke.

Authors:  Tiffany L Mathias; Karen C Albright; Amelia K Boehme; Dominique Monlezun; Alexander J George; Erica Jones; T Mark Beasley; Sheryl Martin-Schild
Journal:  J Cardiovasc Dis       Date:  2014-01

5.  Prevalence of Systemic Atherosclerosis Burdens and Overlapping Stroke Etiologies and Their Associations With Long-term Vascular Prognosis in Stroke With Intracranial Atherosclerotic Disease.

Authors:  Takao Hoshino; Leila Sissani; Julien Labreuche; Gregory Ducrocq; Philippa C Lavallée; Elena Meseguer; Céline Guidoux; Lucie Cabrejo; Cristina Hobeanu; Fernando Gongora-Rivera; Pierre-Jean Touboul; Philippe Gabriel Steg; Pierre Amarenco
Journal:  JAMA Neurol       Date:  2018-02-01       Impact factor: 18.302

6.  B-flow imaging estimation of carotid and femoral atherosclerotic plaques: vessel walls rheological damage or strong predictor of cardiovascular mortality in chronic dialysis patients.

Authors:  Petar Avramovski; Maja Avramovska; Aleksandar Sikole
Journal:  Int Urol Nephrol       Date:  2016-08-11       Impact factor: 2.370

Review 7.  Blood lipids and stroke: what more can we do besides reducing low-density lipoprotein cholesterol?

Authors:  Dominique Deplanque; Pierre Amarenco
Journal:  Curr Atheroscler Rep       Date:  2011-08       Impact factor: 5.113

Review 8.  Subclinical cardiovascular disease in type 2 diabetes mellitus: To screen or not to screen.

Authors:  Juan J Chillarón; Juana A Flores-Le Roux; David Benaiges; Juan Pedro-Botet
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

9.  Interactions between cardiovascular and cerebrovascular disease.

Authors:  Giuseppe Di Pasquale; Stefano Urbinati; Enrica Perugini; Simona Gambetti
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

10.  Risk of a coronary event in patients after ischemic stroke or transient ischemic attack.

Authors:  Ivan Poledník; Jakub Sulzenko; Petr Widimsky
Journal:  Anatol J Cardiol       Date:  2021-03       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.